BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2969387)

  • 21. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Diabetes; 1993 May; 42(5):715-9. PubMed ID: 8482428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol: a renal risk factor in diabetic nephropathy?
    Mulec H; Johnsen SA; Wiklund O; Björck S
    Am J Kidney Dis; 1993 Jul; 22(1):196-201. PubMed ID: 8322783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study.
    Rudberg S; Persson B; Dahlquist G
    Kidney Int; 1992 Apr; 41(4):822-8. PubMed ID: 1513104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concerns about diabetic nephropathy in the treatment of diabetic hypertensive patients.
    Tolins JP; Raij L
    Am J Med; 1989 Dec; 87(6A):29S-33S. PubMed ID: 2688411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy.
    Osterby R; Parving HH; Nyberg G; Hommel E; Jørgensen HE; Løkkegaard H; Svalander C
    Diabetologia; 1988 May; 31(5):265-70. PubMed ID: 3396784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theoretical analysis of pathogenetic mechanisms in experimental acute renal failure.
    Oken DE
    Kidney Int; 1983 Jul; 24(1):16-26. PubMed ID: 6620849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
    Mulec H; Blohmé G; Grände B; Björck S
    Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease--reproducibility, progression, and efficacy of antihypertensive intervention.
    Mogensen CE; Hansen KW; Nielsen S; Pedersen MM; Rehling M; Schmitz A
    Am J Kidney Dis; 1993 Jul; 22(1):174-87. PubMed ID: 8322781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy.
    Passariello N; Sepe J; Marrazzo G; De Cicco A; Peluso A; Pisano MC; Sgambato S; Tesauro P; D'Onofrio F
    Diabetes Care; 1993 May; 16(5):789-95. PubMed ID: 8495620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
    Berglund J
    Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Permissive role of hypertension in the development of proteinuria and progression of renal disease in insulin-dependent diabetic patients.
    Earle KA; Morocutti A; Viberti G
    J Hypertens; 1997 Feb; 15(2):191-6. PubMed ID: 9469795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemorheologic findings in diabetes and their clinical relevance].
    Volger E
    Wien Med Wochenschr; 1986; 136 Spec No():5-10. PubMed ID: 3825172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring glomerular function in diabetic nephropathy. A prospective study.
    Viberti GC; Bilous RW; Mackintosh D; Keen H
    Am J Med; 1983 Feb; 74(2):256-64. PubMed ID: 6401924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diabetes and kidneys: predictors of nephropathy and progression factors].
    González E; Ortiz M; Praga M
    Nefrologia; 2001; 21 Suppl 3():46-51. PubMed ID: 11642207
    [No Abstract]   [Full Text] [Related]  

  • 35. [ACE inhibitor effects on structure and function of the glomerular basement membrane].
    Hasslacher C; Bostedt-Kiesel A; Kempe HP
    Klin Wochenschr; 1992; 69 Suppl 29():39-44. PubMed ID: 1614191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early functional and morphologic vascular renal consequences of the diabetic state.
    Mogensen CE; Osterby R; Gundersen HJ
    Diabetologia; 1979 Aug; 17(2):71-6. PubMed ID: 385406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood rheology and diabetic nephropathy.
    Simpson LO
    Diabetologia; 1990 Sep; 33(9):576-7. PubMed ID: 2253836
    [No Abstract]   [Full Text] [Related]  

  • 38. L-Citrulline, but not L-arginine, prevents diabetes mellitus-induced glomerular hyperfiltration and proteinuria in rat.
    Persson P; Fasching A; Teerlink T; Hansell P; Palm F
    Hypertension; 2014 Aug; 64(2):323-9. PubMed ID: 24866144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes mellitus: its effect on the flow properties of blood.
    Oughton J; Barnes AJ; Kohner EM
    Horm Metab Res Suppl; 1981; 11():112-20. PubMed ID: 6797911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radionuclear determination of glomerular filtration rate and renal plasma flow to detect early decrease of renal function in insulin dependent diabetes.
    Cascone C; Beltramello G; Borsato N; Cavallin F; Calzavara P; De Luca M; Susanna F; Madia D; Zanco P; Saitta B
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():642-8. PubMed ID: 3991557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.